Search

Displaying results 2061 - 2070 of 10000 in total
  1. Drug

    VLX-1005

    go.drugbank.com/drugs/DB18307
    Investigational

  2. Drug

    TOL-101

    go.drugbank.com/drugs/DB16980
    Investigational

    Synonyms: TOL 101, Murine IgM monoclonal antibody specific for the human alpha, beta T cell receptor
  3. Drug

    TLX-102

    go.drugbank.com/drugs/DB32040
    Experimental

    Synonyms: 4-(ASTATO-211AT)-L-PHENYLALANINE, 4-(ASTATO-211AT)-L-PHENYLALANINE 4-(ASTATO-211AT)-L-PHENYLALANINE ABSOLUTE STEREOCHEMISTRY.
  4. Drug

    LS-104

    go.drugbank.com/drugs/DB33597
    Experimental

  5. Drug

    Imiquimod

    go.drugbank.com/drugs/DB00724
    ApprovedInvestigational

    Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production.

    International brands: Li DiProducts: Imikeraderm 50 mg/g Creme
  6. Drug

    SIS-101-ADO

    go.drugbank.com/drugs/DB18085
    Experimental

    SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis Type 2 (ADO2).[L48091]

  7. Drug

    Levodopa

    go.drugbank.com/drugs/DB01235
    ApprovedInvestigational

    Levodopa can be metabolised to dopamine on either side of the blood-brain barrier and so it is generally administered with a dopa decarboxylase inhibitor like carbidopa to prevent metabolism until after … it has crossed the blood-brain barrier[Label,A177781].

    Mixtures: LEVO/CA/E 100/25/200 ABZ, LEVO/CA/E 100/25/200 ABZSynonyms: L-DOPA, 3-Hydroxy-L-tyrosine
  8. Drug

    Adapalene

    go.drugbank.com/drugs/DB00210
    ApprovedInvestigational

    On December 8th, 2008, Galderma Labs gained FDA approval for Epiduo®, a 0.1% adapalene, 2.5% BPO combination gel.[L12873] … It is also associated with _Cutibacterium acnes_ (also known as _Propionibacterium acnes_). Adapalene is a third-generation topical retinoid used for the treatment of acne vulgaris.

    Mixtures: Clindap-TProducts: Proactiv MD Adapalene Acne Treatment, Deriva MS Aqueous Gel 0.1% w/w
  9. Drug

    Momelotinib

    go.drugbank.com/drugs/DB11763
    ApprovedInvestigational

    MF includes primary MF (PMF), post-polycythemia vera (PV) MF, and post-essential thrombocythemia (ET) MF. Clinical manifestations of MF include anemia and thrombocytosis. … It is a competitive inhibitor of JAK ATP binding.[A261566] First approved by the FDA on September 15, 2023,[L48206] momelotinib is used to treat myelofibrosis.

  10. Drug

    Pirenoxine

    go.drugbank.com/drugs/DB15945
    Investigational

    Products: KARY UNI OPHTHALMIC SUSPENSION 0.05 mg/ml